Moderna Starts Tests with Bundibugyo Ebola Vaccine, Outbreak in DR Congo Continues
TL;DR
AI-generated
Moderna has begun a Phase 1 study of an mRNA-based vaccine against the Bundibugyo Ebola virus. The Democratic Republic of Congo continues to experience its second-fastest Ebola outbreak, with 3,802 registered cases and 1,707 deaths.
Source: euronews.com
Same event
- Democratic Republic of Congo: Clinical Studies in the Fight Against Ebola
- Ebola in DR Congo: Uncontrolled Outbreak with Superlatives
- Moderna Starts Tests with Bundibugyo Ebola Vaccine, Outbreak in DR Congo Continues
- WHO: Studies on Ebola drugs and vaccines begin
Discussion
Log in to join the discussion.
No comments yet. Be the first!